Open Access[Corrigendum] Targeting cysteine‑rich angiogenic inducer‑61 by antibody immunotherapy suppresses growth and migration of non‑small cell lung cancer
Author(s) -
Xinpeng Li,
Yuan Na-xin,
Lingdan Lin,
Lin Yin,
Yi-Qing Qu
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11365
Subject(s) - cancer research , immunotherapy , cancer , oncogene , inducer , molecular medicine , antibody , cell , lung cancer , cell cycle , cell growth , medicine , biology , immunology , oncology , biochemistry , gene